Using Normalized Carcinoembryonic Antigen and Carbohydrate Antigen 19 to Predict and Monitor the Efficacy of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer

Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are established prognostic biomarkers for patients with gastric cancer. However, their potential as predictive markers for neoadjuvant chemotherapy (NACT) efficacy has not been fully elucidated. Methods: We conducted a retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xiao-Huan, Wu, Xiao-Long, Gan, Xue-Jun, Wang, Yi-Ding, Jia, Fang-Zhou, Wang, Yi-Xue, Zhang, Yan, Gao, Xiang-Yu, Li, Zi-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418931/
https://www.ncbi.nlm.nih.gov/pubmed/37569566
http://dx.doi.org/10.3390/ijms241512192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418931/
https://www.ncbi.nlm.nih.gov/pubmed/37569566
http://dx.doi.org/10.3390/ijms241512192

Ejemplares similares